PT Siloam International Hospitals Tbk Reg-S (DE:2LS)
FRANKFURT:2LS
2LS Stock Chart & Stats
€0.13
>-€0.01(-1.11%)
At close: 4:00 PM EST
€0.13
>-€0.01(-1.11%)
Day’s Range― - ―
52-Week Range€0.09 - €0.14
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€1.40B
Enterprise Value€1.40B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)21.5
Beta0.07
Next Earnings
Jul 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding13,006,125,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
2LS FAQ
What was PT Siloam International Hospitals Tbk Reg-S’s price range in the past 12 months?
PT Siloam International Hospitals Tbk Reg-S lowest stock price was €0.09 and its highest was €0.14 in the past 12 months.
What is PT Siloam International Hospitals Tbk Reg-S’s market cap?
PT Siloam International Hospitals Tbk Reg-S’s market cap is €1.40B.
When is PT Siloam International Hospitals Tbk Reg-S’s upcoming earnings report date?
PT Siloam International Hospitals Tbk Reg-S’s upcoming earnings report date is Jul 29, 2026 which is in 51 days.
How were PT Siloam International Hospitals Tbk Reg-S’s earnings last quarter?
PT Siloam International Hospitals Tbk Reg-S released its earnings results on Apr 30, 2026. The company reported €0.001 earnings per share for the quarter, beating the consensus estimate of N/A by €0.001.
Is PT Siloam International Hospitals Tbk Reg-S overvalued?
According to Wall Street analysts PT Siloam International Hospitals Tbk Reg-S’s price is currently Overvalued.
Does PT Siloam International Hospitals Tbk Reg-S pay dividends?
PT Siloam International Hospitals Tbk Reg-S does not currently pay dividends.
What is PT Siloam International Hospitals Tbk Reg-S’s EPS estimate?
PT Siloam International Hospitals Tbk Reg-S’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PT Siloam International Hospitals Tbk Reg-S have?
PT Siloam International Hospitals Tbk Reg-S has 13,006,125,000 shares outstanding.
What happened to PT Siloam International Hospitals Tbk Reg-S’s price movement after its last earnings report?
PT Siloam International Hospitals Tbk Reg-S reported an EPS of €0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.847%.
Which hedge fund is a major shareholder of PT Siloam International Hospitals Tbk Reg-S?
Currently, no hedge funds are holding shares in DE:2LS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PT Siloam International Hospitals Tbk Reg-S
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. The company manages and operates multiple hospitals in Jadebotabek. Siloam Hospitals makes investments in both technology and medical staff to offer a range of medical services. The company also manages Centers of Excellence that address medical cases requiring complex treatment. The company derives its revenue from inpatient and outpatient services. Inpatient services derive revenue from medical support and medical specialist services, drugs and medical supplies, and inpatient rooms. Outpatient services derive revenue from medical support services, consultation services, drugs and medical equipment, and registration fees. Inpatient services are responsible for a majority of the company's revenue.
Technical Analysis
Options Prices
Currently, No data available
---